RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+15.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$855M
AUM Growth
+$208M
(+32%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
16.99%
Top 10 Holdings %
Top 10 Hldgs %
33.51%
Holding
104
New
21
Increased
54
Reduced
10
Closed
11
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$9.57M |
| 4 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$9.5M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$8.91M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$13.2M |
| 2 |
Gilead Sciences
GILD
|
$10.2M |
| 3 |
Pacira BioSciences
PCRX
|
$9.89M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$8.92M |
| 5 |
Cardinal Health
CAH
|
$6.91M |
Sector Composition
| 1 | Healthcare | 73.14% |
| 2 | Financials | 1.36% |
| 3 | Technology | 0.94% |
| 4 | Industrials | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVDQ
51
DELISTED
Novadaq Technologies Inc.
NVDQ
| $6.27M | 0.73% |
377,500
+67,500
| +22% | +$1.12M |
|
|
RLYP
52
DELISTED
RELYPSA INC COM
RLYP
| $5.79M | 0.68% |
188,000
+43,000
| +30% | +$1.32M |
|
53
Illumina
ILMN
$15.2B
| $5.63M | 0.66% |
31,354
-6,682
| -18% | -$1.2M |
|
54
Steris
STE
$23.9B
| $5.25M | 0.61% |
+81,000
| New | +$5.25M |
|
|
CNXR
55
DELISTED
Connecture, Inc.
CNXR
| $4.99M | 0.58% |
+554,225
| New | +$4.99M |
|
|
WCG
56
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.92M | 0.58% |
60,000
-16,250
| -21% | -$1.33M |
|
|
ACHN
57
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $4.47M | 0.52% |
+365,000
| New | +$4.47M |
|
|
ZSPH
58
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $4.45M | 0.52% |
107,000
+15,000
| +16% | +$624K |
|
59
Tandem Diabetes Care
TNDM
$837M
| $4.45M | 0.52% |
35,000
+7,300
| +26% | +$927K |
|
60
Puma Biotechnology
PBYI
$252M
| $4.4M | 0.51% |
23,250
+2,750
| +13% | +$521K |
|
61
Theravance Biopharma
TBPH
$696M
| $4.33M | 0.51% |
290,000
+134,500
| +86% | +$2.01M |
|
62
Prothena Corp
PRTA
$443M
| $4.2M | 0.49% |
202,500
| – | – |
|
63
FibroGen
FGEN
$47.1M
| $4.14M | 0.48% |
+6,052
| New | +$4.14M |
|
64
Jazz Pharmaceuticals
JAZZ
$7.83B
| $4.09M | 0.48% |
25,000
+6,750
| +37% | +$1.11M |
|
|
AERI
65
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.09M | 0.48% |
140,000
+40,700
| +41% | +$1.19M |
|
|
AGN
66
DELISTED
ALLERGAN INC
AGN
| $3.93M | 0.46% |
18,500
-4,250
| -19% | -$904K |
|
67
Coherus Oncology, Inc. Common Stock
CHRS
$155M
| $3.92M | 0.46% |
+240,051
| New | +$3.92M |
|
|
CYBX
68
DELISTED
CYBERONICS INC
CYBX
| $3.79M | 0.44% |
68,000
+1,000
| +1% | +$55.7K |
|
69
Novavax
NVAX
$1.23B
| $3.77M | 0.44% |
31,750
+3,000
| +10% | +$356K |
|
|
CTLT
70
DELISTED
CATALENT, INC.
CTLT
| $3.73M | 0.44% |
133,600
-67,400
| -34% | -$1.88M |
|
|
CO
71
DELISTED
Global Cord Blood Corporation
CO
| $3.72M | 0.43% |
822,000
+27,000
| +3% | +$122K |
|
72
Regeneron Pharmaceuticals
REGN
$60.2B
| $3.69M | 0.43% |
+9,000
| New | +$3.69M |
|
|
WX
73
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $3.62M | 0.42% |
107,500
+11,000
| +11% | +$370K |
|
|
INFI
74
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $3.55M | 0.41% |
210,000
| – | – |
|
|
EPZM
75
DELISTED
Epizyme, Inc
EPZM
| $3.43M | 0.4% |
181,500
+50,500
| +39% | +$953K |
|